Carl v. Johnson & Johnson
(N.J., filed October 5, 2020): Urging the New Jersey Supreme Court to review a lower court’s incorrect application of the state’s expert evidence standard. Arguing that the Court needs to overturn the decision to reinforce the message of its opinion in In re Accutane. The opinion, if not reversed, will leave trial courts with great uncertainty as to the gatekeeping role in New Jersey’s many drug, tort and product lawsuits.
ATRA’s statement on passage of Amendment 1 to Illinois House Bill 3360
ATRA’s statement on Amendment 1 to Illinois House Bill 3360
ATRA President Tiger Joyce released the following statement in response to the unprecedented attack on the U.S. Capitol building on January 6:
ATRA voices its disappointment as Congress fails to include liability protections in its latest COVID-19 relief package.
ATRA President Tiger Joyce writes in this op-ed about a growing trend of state courts bucking SCOTUS precedent when it comes to personal jurisdiction.
Activism in AG’s office, Supreme Court’s acceptance of lawsuit funding and loose venue rules to blame